Aehr Test Systems, Inc. (AEHR), a Fremont, California-based maker of semiconductor test and burn-in equipment used to screen chips for early-life failures, rallied sharply in today's session. Shares climbed roughly 12.39%, or about $7.38, to trade near $66.95, up from a prior close of $59.57. The move marks the latest leg in a whipsaw rally that has followed the company's better-than-expected fiscal first-quarter earnings and a higher full-year revenue outlook, both built on accelerating demand for burn-in testing of artificial-intelligence processors.
The primary driver behind the renewed buying is sustained enthusiasm for AEHR's exposure to the AI hardware buildout. Burn-in testing subjects chips to heat and electrical stress to identify early-life failures before costly devices are packaged and shipped. As AI processors grow larger, more power-hungry, and more expensive—often bundling multiple compute dies with high-bandwidth memory and optical I/O—reliability screening has become a critical, and increasingly expensive, step in the supply chain.
AEHR addresses this with its FOX wafer-level burn-in systems and its Sonoma high-power, package-level platform. Management has pointed to expanding production demand across both product lines, including a lead hyperscale customer whose second AI processor has completed qualification and is expected to reach higher volumes than its first.
The rally builds on a quarter that reshaped the company's financial profile. For its fiscal 2027 first quarter, AEHR reported record revenue of $33.0 million, up about 200% year over year and 75% sequentially, alongside non-GAAP earnings per share of $0.28, which comfortably exceeded Wall Street estimates. Bookings of $46.7 million produced a book-to-bill ratio of roughly 1.4, and effective backlog reached about $109.3 million as of November 1.
On the strength of that visibility, the company raised its fiscal 2027 revenue outlook to $150 million—the top of its prior $130 million-to-$150 million range—and said it expects non-GAAP net income of at least 20% of revenue. The combination of record top-line growth, an improving margin profile, and a backlog that covers most of the full-year target has kept buyers engaged even amid the stock's sharp swings.
A secondary catalyst arrived in the form of a regulatory disclosure. A Schedule 13G filing revealed that Jane Street Group and its affiliates have accumulated a combined beneficial stake of roughly 5.1% of AEHR's outstanding shares. While 13G filings reflect passive investment positions rather than activist intent, the disclosure signaled growing institutional attention toward the name and reinforced the positive momentum already in place.
The move also aligns with broader strength across the semiconductor-equipment and AI-hardware complex. Investors have continued to reward companies with direct exposure to the buildout of AI data-center infrastructure, and AEHR's pivot away from its legacy silicon-carbide and electric-vehicle testing business toward AI processors, silicon photonics, and data-center chips has positioned it squarely within that narrative.
The session's advance lifted AEHR back above its 20-day moving average of roughly $60, a level that had acted as resistance in recent sessions. The stock remains below its longer-term 50-day and 200-day averages near $79 and $75, respectively, and well off its 52-week high of $147.40 reached in mid-August. Trading has been exceptionally volatile since the earnings release, with the shares logging several double-digit percentage swings as investors reassess both the fundamental growth story and an elevated valuation that trades at a substantial premium to historical norms.
Looking ahead, investors will focus on execution against the company's raised revenue target and the pace of system shipments to key customers. The company has indicated it expects sequential revenue growth through the remaining quarters of its fiscal year, with a strong second quarter supported by deliveries already in backlog. A pivotal milestone is the early-2027 installation of a full FOX-XP wafer-level burn-in test cell at a partner facility in Taiwan for a major AI accelerator supplier, with a potential high-volume production decision expected within months of validation.
Risks remain. Customer concentration is high, quarterly results can be lumpy, and the stock's premium valuation leaves it sensitive to any shift in AI-infrastructure spending sentiment. Margin mix and working-capital swings tied to inventory and receivables also bear watching as the company scales manufacturing capacity.
Tickeron offers hundreds of AI-powered trading bots that analyze thousands of tickers, but only the strongest performers under current market conditions are showcased in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a range of automated approaches to explore. To see which strategies are leading the market today, visit the Trending AI Robots page.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for AEHR turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 36 of 38 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Indicator exited the oversold zone, 26 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 56 cases where AEHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
AEHR moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AEHR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment